FDA Fast Track Designation Sends Biotech Soaring Mid-Week
12 Febbraio 2025 - 10:10PM
AllPennyStocks.com
A California-based biotech found some serious
success on Wednesday after the company received FDA fast track
designation for Troculeucel, used for the treatment of
moderate...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni NKGen Biotech (NASDAQ:NKGN)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni NKGen Biotech (NASDAQ:NKGN)
Storico
Da Mar 2024 a Mar 2025
